Fideres provided comprehensive consulting expert analysis in NECA IBEW Welfare Trust Fund v. Akorn Inc. (Case No. 1:16-cv-08109), part of MDL 2724 In re Generic Pharmaceuticals Pricing Antitrust Litigation, examining plus factor analysis and collusive pricing patterns in the generic clobetasol propionate market.

Fideres conducted detailed econometric analysis of clobetasol pricing behavior and market dynamics, examining parallel pricing movements and coordination indicators among competing pharmaceutical manufacturers. The consulting expert analysis employed statistical methodologies including structural break analysis and cross-correlation studies to identify plus factors demonstrating anticompetitive coordination contrary to independent competitive behavior.

The comprehensive economic analysis provided evidentiary support for allegations of systematic price-fixing conspiracies affecting the generic clobetasol market, part of broader Department of Justice investigations resulting in over $681 million in criminal penalties against seven generic pharmaceutical companies, with major settlements specifically identifying clobetasol among drugs subject to manipulation schemes.